10.25384/SAGE.7441256.v2
G. Caleb Alexander
G. Caleb
Alexander
Ken Ogasawara
Ken
Ogasawara
Dana Wiegand
Dana
Wiegand
Dora Lin
Dora
Lin
Christopher D. Breder
Christopher D.
Breder
Supplemental Material, 812058_web_appendix - Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016
SAGE Journals
2019
drug approval
regulatory affairs
expedited programs
2019-11-26 13:08:07
Journal contribution
https://sage.figshare.com/articles/journal_contribution/Supplemental_Material_812058_web_appendix_-_Clinical_Development_of_Biologics_Approved_by_the_US_Food_and_Drug_Administration_2003-2016/7441256
<p>Supplemental Material, 812058_web_appendix for Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016 by G. Caleb Alexander, Ken Ogasawara, Dana Wiegand, Dora Lin, and Christopher D. Breder in Therapeutic Innovation & Regulatory Science</p>